Metallopeptidases produced by group B Streptococcus: Influence of proteolytic inhibitors on growth and on interaction with human cell lineages

International Journal of Molecular Medicine

Volumn 22, Issue 1, 2008, Pages 119-125

  Soares, Georgia Cristina Monteiro Tavolaro ^a   da Silva, Bianca Alcântara ^b   dos Santos, Michelle Hanthequeste Bittencourt ^a   da Costa, Andréia Ferreira Eduardo ^a   dos Santos, André Luis Souza ^b   Morandi, Verônica ^a   Nagao, Prescilla Emy ^a  

^a STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Cellular interaction; Group B streptococcus; Metalllopeptidase inhibitors; Peptidase

Indexed keywords

ALBUMIN; AMPICILLIN; CEFTAZIDIME; CLINDAMYCIN; COLLAGEN TYPE 4; COTRIMOXAZOLE; EGTAZIC ACID; ERYTHROMYCIN; FIBRINOGEN; FIBRONECTIN; GELATIN; IMIPENEM; LAMININ; METALLOPROTEINASE; METALLOPROTEINASE INHIBITOR; NORFLOXACIN; PENICILLIN G; PHENANTHROLINE; TETRACYCLINE; UNCLASSIFIED DRUG; VANCOMYCIN; ZINC METALLOPROTEINASE; PROTEINASE INHIBITOR;

ARTICLE; BACTERIAL GROWTH; BACTERIAL TRANSMISSION; BACTERIAL VIRULENCE; CELL INTERACTION; CELL LINEAGE; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME SYNTHESIS; EXTRACELLULAR MATRIX; GROWTH INHIBITION; HUMAN; HUMAN CELL; MOLECULAR WEIGHT; NONHUMAN; PATHOGENESIS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS INFECTION; SUPERNATANT; CELL LINE; CELL PROLIFERATION; CYTOLOGY; DRUG EFFECT; ENZYMOLOGY; METABOLISM; PROTEIN PROCESSING;

CELL LINE; CELL LINEAGE; CELL PROLIFERATION; HUMANS; METALLOPROTEASES; PROTEASE INHIBITORS; PROTEIN PROCESSING, POST-TRANSLATIONAL; STREPTOCOCCUS AGALACTIAE;

EID: 52049097543     PISSN: 11073756     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijmm.22.1.119     Document Type: Article

References (36)

1. Gibbs RS, Schrang S and Schuchat A: Perinatal infections due to group B streptococci. Obstet Gynecol 104: 1062-1076, 2004.
2. Blumberg HM, Stephes DS and Modansky M: Invasive group streptococcal disease: the emergency of serotype V. J Infect Dis 173: 365-373, 1996.
3. Teixeira CF, Azevedo NL, Carvalho TMU, Fuentes J and Nagao PE: Cytochemical study of Streptococcus agalactiae and macrophage interaction. Microsc Res Tech 54: 254-259, 2001.
4. Lalioui L, Pellegrini E, Dramsi S, Baptista M, Bourgeois N, Doucet-Populaire F, Rusniok C, Zouine M, Glaser P, Kunst F, Poyart C and Trieu-Cuot P: The SrtA sortase of Streptococcus agalactiae is required for cell wall anchoring of proteins containing the LPXTG motif, for adhesion to epithelial cells, and for colonization of the mouse intestine. Infect Immun 73: 3342-3350,2005.
5. Jones S, Athan E and Viggers J: Prevention of recurrent fetal death in utero due to group B streptococcal chorioamnionitis. Aust J Obstet Gynaecol 44: 356-357, 2004.
6. Winram SB, Jonas M, Chi E and Rubens CE: Characterization of group B streptococcal invasion of human chorion and amnion epithelial cells in vitro. Infect Inunun 66: 4932-4941, 1998.
7. Rubens CE, Raff HV, Jackson JC, Chi EY, Bielitzki JT and Hillier SL: Pathophysiology and bistopathology of group B streptococcal sepsis in Macaca nemestrina primates induced after intraamniotic inoculation: evidence for bacterial cellular invasion. J Infect Dis 164: 320-330, 1991.
8. Doran KS and Nizet V: Molecular pathogenesis of neonatal group B streptococcal infection: no longer in its infancy. Mol Microbiol 54: 23-31, 2004.
9. Jackson RJ, Dao ML and Lim DV: Cell-associated collagenolytic activity by group B streptococci. Infect Immun 62: 5647-5651, 1994.
10. Lin B, Averett WF, Novak J, Chatham WW, Hollingshead SK, Coligan JE, Egan ML and Pritchard DG: Characterization of PepB, a group B streptococcal oligopeptidase. Infect Immun 64: 3401-3406, 1996.
11. Beckmann C, Waggoner JD, Harris TO, Tamura GS and Rubens CE: Identification of novel adhesins from group B streptococci by use of phage display reveals that C5a peptidase mediates fibronectin binding. Infect Immun 70: 2869-2876, 2002.
12. Cheng QI, Stafslien D, Purushothaman SS and Cleary P: The group B streptococcal C5a peptidase is both a specific protease and an invasion. Infect Immun 70: 2408-2413, 2002.
13. Santos GS, Miyazaki NHT, Mattos-Guaraldi AL and Nagao PE: The effects of interferon-γ and transforming growth factor-β on adherence and survival of group B Streptococcus type III strains in ECV304 cells. Int J Mol Med 11: 401-406, 2003.
14. Lancefield RD: Serological differentiation of human and other groups of hemolytic streptococci. J Exp Med 57: 571-595, 1933.
15. Palmeira VF, Kneipp LF, Alviano CS and Santos ALS: The major chromoblastomycosis fungal pathogen Fonsecaea pedrosoi extracellularly releases proteolytic enzymes whose expression is modulated by culture medium composition: implications on the fungal development and cleavage of key host structures. FEMS Immunol Med Microbiol 46: 21-29, 2006.
16. Lowry OH, Rosebrough NJ, Farr AL and Randall RJ: Protein measurement with the folin phenol reagent. J Biol Chem 193: 265-275, 1951.
17. Jaffe EA, Nacchman RL, Becker CG and Minick CR: Culture of human endothelial cells derived from umbilical cord veins. Identification by morphologic and immunologic criteria. J Clin Invest 52: 2745-2756, 1973.
18. Lantz MS: Are bacterial proteases important virulence factors? J Periodontal Res 32: 126-132, 1997.
19. Lähteenmäki AK, Pentti K and Korhonen TK: Bacterial plasminogen activators and receptors. FEMS Microbiol Rev 25: 531-555, 2001.
20. Maeda H and Yamamoto T: Pathogenic mechanisms induced by microbial proteases in microbial infections. Biol Chem Hoppe Seyler 377: 217-226, 1996.
21. Gaillot O, Pellegrini E, Bregenholt S, Nair S and Berche P: The ClpP serine protease is essential for the intracellular parasitism and virulence of Listeria monocytogenes. Mol Microbiol 35: 1286-1294, 2000.
22. Lione VOF, Santos GS, Hirata R Jr, Mattos-Guaraldi AL and Nagao PE: Involvement of intercellular adhesion molecule-1 and beta 1 integrin in the internalization process to human endothelial cells of group B Streptococcus clinical isolates. Int J Mol Med 15: 153-157, 2005.
23. São José AS, Miyazaki NHT, Hirata R Jr, Mattos-Guaraldi AL and Nagao PE: Intracellular viability in non-polarized respiratory epithelial 16 HBE 14o- cells by group B Streptococcus serotype III clinical isolates presenting 162-kb and 183-kb virulence markers. Int J Mol Med 17: 533-538, 2006.
24. Miyoshi S and Shinoda S: Microbial metalloproteases and pathogenesis. Microb Infect 2: 91-98, 2000.
25. Wu S, Dreyfus LA, Tzianabos AO, Hayashi C and Sears CL: Diversity of the metalloprotease toxin produced by enterotoxigenic Bacteroides fragilis. Infect Immun 70: 2463-2471, 2002.
26. Butler HM, Hurse A, Thursky E and Shulman A: Bactericidal action of selected phenanthroline chelates and related compounds. Aust J Exp Biol Med Sci 47: 541-552, 1969.
27. Dwyer FP, Reid IK, Shulman A, Laycock GM and Dixson S: The biological actions of 1,10-phenanthroline and 2,2-bipyridine hydrochlorides, quaternary salts and metal chelates and related compounds. Bacteriostatic action on selected grain-positive, gram-negative and acid-fast bacteria. Aust J Exp Biol Med Sci 47: 203-218, 1969.
28. Valentin-Weigand P, Benkel P, Rohde M and Chhatwal GS: Entry and intracellular survival of group B streptococci in J774 macrophages. Infect Immun 64: 2467-2473, 1996.
29. Gibson RL, Soderland C, Henderson WR, Chi EY and Rubens CE: Group B streptococci (GBS) injure lung endothelium in vitro: GBS invasion and GBS-induced icosanoid production is greater with microvascular than with pulmonary artery cells. Infect Immun 63: 271-279, 1995.
30. Valentin-Weigand P and Chhatwal GS: Correlation of epithelial cell invasiveness of group B streptococci with clinical source of isolation. Microb Pathog 19: 83-91, 1995.
31. Maisey HC, Hensler M, Nizet V and Doran KS: Group B streptococcal pilus proteins contribute to adherence to and invasion of brain microvascular endothelial cells. J Bacteriol 189: 1464-1467, 2007.
32. Tenenbaum T, Bloier C. Adam R. Reinscheid DJ and Schroten H: Adherence to and invasion of human brain microvascular endothelial cells are promoted by fibrinogen-binding protein FbsA of Streptococcus agalactiae. Infect Immun 73: 4404-4409, 2005.
33. Glaser P, Rusniok C, Buchrieser C. Chevalier F. Frangeul L, Msadek T, Zouine M, Couvé E, Lalioui L, Poyart C. Trieu-Cuot P and Kunst F: Genome sequence of Streptococcus agalactiae, a pathogen causing invasive neonatal disease. Mol Microbiol 45: 1499-1513, 2002.
34. Tong HH, Blue LE, James MA and De Maria TF: Evaluation of the virulence of a Streptococcus pneumoniae neuraminidase-deficient mutant in nasopharyngeal. colonization and development of otitis media in the chinchilla model. Mol Microbiol 68: 921-924, 2000.
35. Job D. Wann ER, Kreikemeyer B, Speziale P and Hook M: Role of fibronectin-binding MSCRAMMs in bacterial adherence and entry into mammalian cells. Matrix Biol 18: 211-223, 1999.
36. Tamura GS, Kuypers JM, Smith S, Raff H and Rubens CE: Adherence of group B streptococci to cultured epithelial cells: roles of environmental factors and bacterial surface components. Infect Immun 62: 2450-2458, 1994.